Samalin Investment Counsel, LLC Intercept Pharmaceuticals, Inc. Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $280 - $489	-25 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $386 - $612	25 New	25 $0
Q1 2021 May 11, 2021	SELL	$19.33 - $37.75 $483 - $943	-25 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$39.09 - $53.44 $977 - $1,336	25 New	25 $1,000
Q1 2020 May 04, 2020	SELL	$48.35 - $118.68 $6,623 - $16,259	-137 Closed	0 $0

Q4 2019 Feb 05, 2020	BUY	$57.36 - $124.1 $7,858 - $17,001	137 New	137 $16,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.